Ive never seen a doctor be that confident. The man flew to Orlando, where Lee injected him with BPC-157
When activated, these receptors trigger several beneficial effects: Enhanced insulin secretion The pancreas releases insulin in response to elevated blood glucose levels, but only when needed (glucose-dependent mechanism) Reduced glucagon release Glucagon, which raises blood sugar, is suppressed when glucose levels are adequate Delayed gastric emptying Food moves more slowly from the stomach into the intestines, promoting satiety Appetite regulation Signals to the brain's appetite centres reduce hunger and food intake Unlike naturally occurring GLP-1, which is rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes, pharmaceutical GLP-1 receptor agonists are chemically modified to resist this degradation
Shes looking at many avenues to see the real issue before helping
Rather than directly activating GABA-A receptors, the peptide appears to maintain homeostasis of the entire GABA receptor complex, preventing the desensitization and compensatory changes that produce tolerance and dependence
The key point: BPC-157 should only be considered with guidance from a licensed provider who understands peptide therapy, safety, and current regulations